We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-0.96%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$273M
AUM Growth
-$56.5M
Cap. Flow
-$54.5M
Cap. Flow %
-20%
Top 10 Hldgs %
37.85%
Holding
118
New
32
Increased
13
Reduced
18
Closed
50

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$9.34M
2
ABBV icon
AbbVie
ABBV
+$9.18M
3
HOLX
Hologic
HOLX
+$8.27M
4
BCR
CR Bard Inc.
BCR
+$7.93M
5
IEV icon
iShares Europe ETF
IEV
+$7.1M

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$9.7M
2
ABT icon
Abbott
ABT
+$8.67M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$8.13M
4
LLY icon
Eli Lilly
LLY
+$7.49M
5
NVS icon
Novartis
NVS
+$7.27M

Sector Composition

Rank Sector Weight
1 Healthcare 52.58%
2 Industrials 3.66%
3 Financials 1.77%
4 Technology 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
76
GSK
GSK
$102B
– –
-120,286
Closed -$6.49M
HCA icon
77
PUT
HCA Healthcare
HCA
$89.2B
– –
-140,000
Closed -$10.6M
JAZZ icon
78
Jazz Pharmaceuticals
JAZZ
$16.1B
– –
-33,936
Closed -$4.12M
LLY icon
79
CALL
Eli Lilly
LLY
$1.09T
– –
-81,500
Closed -$6.54M
LLY icon
80
Eli Lilly
LLY
$1.09T
– –
-93,375
Closed -$7.49M
MOH icon
81
Molina Healthcare
MOH
$10.2B
– –
-70,000
Closed -$4.08M
NVS icon
82
Novartis
NVS
$295B
– –
-102,812
Closed -$7.27M
OFIX icon
83
Orthofix Medical
OFIX
$429M
– –
-70,000
Closed -$2.99M
PBYI icon
84
Puma Biotechnology
PBYI
$454M
– –
-49,125
Closed -$3.29M
PODD icon
85
Insulet
PODD
$10B
– –
-74,600
Closed -$3.05M
RARE icon
86
Ultragenyx Pharmaceutical
RARE
$2.62B
– –
-39,750
Closed -$2.82M
RCKT icon
87
Rocket Pharmaceuticals
RCKT
$377M
– –
-27,867
Closed -$1.06M
DCOY
88
Decoy Therapeutics
DCOY
$2.09M
– –
0
– -$1.67M
SRPT icon
89
Sarepta Therapeutics
SRPT
$1.87B
– –
-40,000
Closed -$2.46M
SYK icon
90
CALL
Stryker
SYK
$134B
– –
-75,000
Closed -$8.73M
SYK icon
91
Stryker
SYK
$134B
– –
-84,333
Closed -$9.7M
THC icon
92
CALL
Tenet Healthcare
THC
$21.1B
– –
-150,000
Closed -$3.4M
THC icon
93
Tenet Healthcare
THC
$21.1B
– –
-105,000
Closed -$2.38M
THC icon
94
PUT
Tenet Healthcare
THC
$21.1B
– –
-200,000
Closed -$4.53M
ZBH icon
95
Zimmer Biomet
ZBH
$18.6B
– –
-41,872
Closed -$5.29M
AVGR
96
CALL
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
-1
Closed -$716K
AVGR
97
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
-5
Closed -$2.73M
TTOO
98
DELISTED
T2 Biosystems, Inc
TTOO
– –
-12
Closed -$441K
DMK
99
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-3,643
Closed -$875K
ISEE
100
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-37,200
Closed -$1.72M
1 2 3
4
5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2016 Portfolio in Review

As of Q4 2016, Pura Vida Investments held 118 positions worth $273M, down 17% from $329M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $54.5M in Q4 2016, closing 50 positions and reducing 18 holdings. Its most notable exit was Stryker, an estimated $9.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 62% a quarter earlier, followed by Industrials and Financials.

Against the trend, Pura Vida Investments opened a new position in UnitedHealth worth $10M.

  • Pura Vida Investments's largest Q4 2016 buy was UnitedHealth: 62,500 shares worth $10M.
  • Pura Vida Investments added most to Athenahealth, Inc. in Q4 2016, an estimated $4.3M increase.
  • Pura Vida Investments's biggest Q4 2016 reduction was Aetna Inc, cutting an estimated $3.63M.
  • Pura Vida Investments fully exited Stryker in Q4 2016, selling an estimated $9.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $273M portfolio in Q4 2016.
  • Pura Vida Investments opened 32 new positions and closed 50 in Q4 2016.
  • Pura Vida Investments's portfolio value fell 17% quarter-over-quarter to $273M.

Based on Pura Vida Investments's 13F filing for Q4 2016, filed 14 Feb 2017.